In VivoRising Leaders Home There is no age restriction to being included in the Rising Leaders list; the 30 people below were recognized for bringing something new to the game. The list focuses on achieveme
In VivoIf deal activity, capital investment and quantity of active clinical trials are any indication, the gene therapy sector will continue its growth spurt in 2021. At the end of the third quarter of 2020,
In VivoRegenerative medicines have made significant advancements in patient care, especially for rare diseases and small patient populations who no longer have to fear being told there are no other options.
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Emmaus, Kainos Tie Up To Develop IRAK4